New stock news | Leebon Pharmaceuticals (09637.HK) introduces 11 top cornerstone investors, creating the strongest lineup in the Hong Kong stock market in recent years.

According to the Wise Finance APP, Hong Kong's 18A has experienced eight years of wind and rain, and the industry has long bid farewell to the era of "story-driven" brutal growth. After multiple rounds of valuation clearing and liquidity differentiation, the market pricing logic has been fundamentally reconstructed: from chasing elusive future imagination to anchoring three core benchmarks of clinical realization certainty, commercialization landing capability, and global capital recognition.